89.18
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$88.08
Aprire:
$88
Volume 24 ore:
927.34K
Relative Volume:
0.64
Capitalizzazione di mercato:
$10.16B
Reddito:
$13.38B
Utile/perdita netta:
$418.00M
Rapporto P/E:
26.93
EPS:
3.3112
Flusso di cassa netto:
$391.00M
1 W Prestazione:
+0.08%
1M Prestazione:
+5.66%
6M Prestazione:
+9.17%
1 anno Prestazione:
+34.92%
Henry Schein Inc Stock (HSIC) Company Profile
Nome
Henry Schein Inc
Settore
Industria
Telefono
(631) 843-5500
Indirizzo
135 DURYEA RD, MELVILLE, NY
Compare HSIC vs MCK, COR, CAH, AHG
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
HSIC
Henry Schein Inc
|
89.18 | 9.64B | 13.38B | 418.00M | 391.00M | 3.3112 |
|
MCK
Mckesson Corp
|
901.77 | 99.52B | 403.43B | 5.10B | 5.41B | 38.47 |
|
COR
Cencora Inc
|
333.87 | 60.54B | 328.68B | 2.55B | 1.56B | 13.03 |
|
CAH
Cardinal Health Inc
|
240.26 | 53.72B | 250.74B | 1.55B | 4.39B | 6.5398 |
|
AHG
Akso Health Group Adr
|
1.39 | 1.25B | 14.85M | -136.07M | 7.25M | -0.4726 |
Henry Schein Inc Stock (HSIC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-16 | Iniziato | BTIG Research | Neutral |
| 2026-04-15 | Iniziato | Citigroup | Buy |
| 2026-02-23 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2025-12-09 | Iniziato | Barclays | Overweight |
| 2025-08-26 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2025-07-25 | Downgrade | Stifel | Buy → Hold |
| 2025-07-14 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2025-02-14 | Iniziato | Wells Fargo | Equal Weight |
| 2025-01-06 | Aggiornamento | BofA Securities | Underperform → Buy |
| 2024-12-04 | Iniziato | Mizuho | Neutral |
| 2024-07-22 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2024-02-26 | Iniziato | Leerink Partners | Market Perform |
| 2023-12-12 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2023-11-10 | Aggiornamento | Stifel | Hold → Buy |
| 2022-08-08 | Aggiornamento | UBS | Sell → Neutral |
| 2022-07-21 | Downgrade | Goldman | Buy → Neutral |
| 2022-06-14 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2022-05-13 | Ripresa | Credit Suisse | Outperform |
| 2022-01-31 | Iniziato | Morgan Stanley | Underweight |
| 2022-01-07 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2021-10-01 | Ripresa | Credit Suisse | Neutral |
| 2021-02-08 | Ripresa | Piper Sandler | Overweight |
| 2021-01-04 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2020-11-03 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2020-05-06 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2020-04-07 | Aggiornamento | Goldman | Neutral → Buy |
| 2020-04-02 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2020-01-09 | Downgrade | BofA/Merrill | Neutral → Underperform |
| 2020-01-02 | Aggiornamento | Evercore ISI | Underperform → In-line |
| 2019-08-07 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2019-05-30 | Iniziato | Wolfe Research | Underperform |
| 2019-05-15 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2019-04-18 | Iniziato | Guggenheim | Buy |
| 2019-01-17 | Iniziato | UBS | Sell |
| 2019-01-03 | Downgrade | Evercore ISI | In-line → Underperform |
| 2019-01-02 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2018-11-08 | Reiterato | Barrington Research | Outperform |
| 2018-10-25 | Downgrade | Edward Jones | Hold → Sell |
| 2018-10-19 | Ripresa | Goldman | Neutral |
| 2018-10-04 | Reiterato | Robert W. Baird | Outperform |
| 2018-08-07 | Reiterato | Stifel | Hold |
| 2018-04-24 | Downgrade | Goldman | Buy → Neutral |
| 2018-04-04 | Aggiornamento | Leerink Partners | Mkt Perform → Outperform |
Mostra tutto
Henry Schein Inc Borsa (HSIC) Ultime notizie
UBS Lifts Price Target on Henry Schein to $89 From $85, Maintains Neutral Rating - marketscreener.com
Henry Schein Prepares to Report Q2 Earnings: What's in the Cards? - TradingView
Henry Schein Inc. stock underperforms Monday when compared to competitors - MarketWatch
Henry Schein Inc (HSIC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Henry Schein, Inc. (HSIC) Stock Analysis: Navigating Growth In Medical Distribution - DirectorsTalk Interviews
Henry Schein stock stays tied to earnings, margins and market value. - AD HOC NEWS
Henry Schein (HSIC) Q1 2026 Earnings Call Transcript - Fortune
Henry Schein Inc (HSIC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Q4 2025 Henry Schein Inc Earnings Call Transcript - GuruFocus
Henry Schein Inc. (HSIC) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
Henry Schein Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Henry Schein Inc (HSIC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
HSIC|Henry Schein Inc|Price:85.970|Chg%:+0.500 - TradingKey
HSIC|Henry Schein Inc|Price:85.470|Chg%:+0.940 - TradingKey
Henry Schein, Inc. (HSIC) Stock Price, News, Quote & History - Yahoo! Finance Canada
Henry Schein, Inc. (HSIC) stock price, news, quote and history - Yahoo Finance Australia
Frederick M. Lowery - Long Island Business News
Henry Schein Inc (HSIC) Institutional Confidence - TradingKey
Henry Schein | 4: Statement of changes in beneficial ownership of securities-Officer Popeck Thomas C - Moomoo
Are Investors Undervaluing Henry Schein (HSIC) Right Now? - Yahoo Finance
Henry Schein, Inc. (HSIC) Stock Forecasts - Yahoo Finance
Henry Schein Inc. stock outperforms competitors despite losses on the day - MarketWatch
Henry Schein (HSIC) Could Be 3% Undervalued As Earnings Come Into Focus - Yahoo Finance
Henry Schein to Report Q2 Earnings: What's in Store for the Stock? - MSN
Black Talon Announces Collaboration with Henry Schein One to Bring Continuous Cyber Readiness to Dental Practices - EIN News
Henry Schein to announce Q2 2026 results on August 4 - scanx.trade
Press Release: Henry Schein to Webcast Second Quarter 2026 Conference Call on Tuesday, August 4, 2026, at 8:00 A.m. ET - Moomoo
Henry Schein to Webcast Second Quarter 2026 Conference Call on Tuesday, August 4, 2026, at 8:00 a.m. ET - Yahoo Finance
Henry Schein stock trades steady as dental and medical distribution margins hold after recent earnin - AD HOC NEWS
What to expect from Henry Schein's next quarterly earnings report - MSN
Henry Schein One goes AI-native with AI Product Discovery and Strategy - Amazon Web Services (AWS)
Will Henry Schein (HSIC) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance
Henry Schein stock trades steady as dental and medical demand supports earnings outlook - AD HOC NEWS
Leerink Partners Adjusts Price Target on Henry Schein to $88 From $83, Maintains Market Perform Rating - marketscreener.com
Henry Schein (HSIC) Baird Global Healthcare Conference 2025 Summary - Quartr
Henry Schein stock trades steady as recent earnings highlight margin resilience - ad-hoc-news.de
Henry Schein stock steady as investors weigh margin trends and dental demand - ad-hoc-news.de
Henry Schein stock stays anchored by 2025 sales and margin trends - Ad Hoc News
Henry Schein (HSIC) Q4 2024 earnings summary - Quartr
Henry Schein Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Henry Schein stock hits 52-week high at 89.34 USD - Investing.com UK
Henry Schein stock hits 52-week high at 89.34 USD By Investing.com - Investing.com South Africa
Henry Schein stock reflects steady healthcare distribution business - ad-hoc-news.de
What to Expect From Henry Schein's Next Quarterly Earnings Report - Barchart.com
Henry Schein stock holds steady as dental and medical distribution remains a core healthcare backbon - ad-hoc-news.de
Henry Schein Inc. stock outperforms competitors on strong trading day - MarketWatch
Henry Schein stock reflects steady health-care distribution business - ad-hoc-news.de
Multi-year Support for Henry Schein Innovation Laboratory - The Medical University of South Carolina
Henry Schein Modestly Gains as Healthcare Demand Remains ResilientPercent Below MA - DonanımHaber
Is Now The Time To Look At Buying Henry Schein, Inc. (NASDAQ:HSIC)? - Moomoo
BMO Capital Maintains Henry Schein(HSIC.US) With Hold Rating, Raises Target Price to $85 - Moomoo
Henry Schein Inc Azioni (HSIC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):